The Current State Of FDA-Approved AI-Enabled Medical Devices.
Summary
This article provides an overview of the current landscape of AI-enabled medical devices that have received FDA approval, highlighting trends and regulatory progress in healthcare technology.
View Cached Full Text
Cached at: 05/11/26, 04:34 PM
Similar Articles
FDA Shortens Clinical Trial Timelines for Drugs and Medical Devices with AI
The FDA launches a pilot program using Causal AI to shorten clinical trial timelines for drugs and medical devices, potentially reducing trial duration by 20-40% and speeding regulatory approval.
AI on Campus
Four top university students discuss the current state of AI on campus, highlighting usage challenges, the 'gray area' of regulations, and how AI empowers non-technical students to build projects. The article emphasizes that responsible AI usage depends on student intent, distinguishing between using AI as a shortcut versus a tool for deep learning.
Frontier AI regulation: Managing emerging risks to public safety
OpenAI proposes a regulatory framework for 'frontier AI' models that pose potential public safety risks, advocating for standard-setting processes, registration/reporting requirements, and compliance mechanisms including pre-deployment risk assessments and post-deployment monitoring.
Reviewed 250+ real AI implementations, a few things surprised me...
The author shares insights from reviewing 250+ real-world AI implementations, highlighting that Engineering and Finance are leading adoption while most outcomes focus on speed rather than cost reduction or revenue growth.
Major U.S. AI Labs Now Subject to Pre-Release Government Security Reviews
The U.S. government has established voluntary pre-release security review agreements with every major domestic AI lab, marking a significant step in federal oversight of frontier model development. The policy aims to proactively assess national security risks before powerful AI systems are publicly deployed.